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Abstract
Background: Orbital inflammatory pseudotumor is a rare inflammatory condition of unknown cause that may
extend intracranially, usually as a dural-based infiltrate. Here we report the first case of orbital pseudotumor
presenting with intra-axial Magnetic Resonance Imaging (MRI) changes.
Case presentation: A 57-year-old white female, with a 3-month history of headache and right palpebral edema,
presented with marked right temporal lobe edema with ominous MRI appearance, and ipsilateral alterations of
orbital and periorbital structures. Following steroid therapy, both intracranial and orbital involvement dramatically
improved.
Conclusion: Orbital inflammatory pseudotumor with chronic inflammation may infrequently present with
intracranial involvement, mimicking more aggressive diseases, even showing intra-axial enhancement after i.v.
contrast administration in brain MRI. Awareness of this possibility may help neurologists to choose the appropriate
therapeutic approach.
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Background
Inflammatory pseudotumor is a rare benign condition of
unknown cause, characterized by unencapsulated mass-
like aggregates of myofibroblastic spindle cells and in-
flammatory cells, including lymphocytes [1]. It has been
described in almost any location, with no age- or sex-
preference, although most commonly in the lung and
orbit [2]. Orbital inflammatory pseudotumor ranks third
after Graves’ and lymphoproliferative diseases among the
most common orbital pathologies [3], and accounts for ap-
proximately 5–8 % of all orbital masses. It may present as
an acute, subacute, or chronic unilateral myositis or
dacryoadenitis, but a wide range of orbital content involve-
ment [4, 5] and clinical presentations are possible, including
proptosis, diplopia, conjunctival chemosis, visual disability,
restriction of extraocular muscle movement, unilateral
periorbital pain, and cranial nerve palsies, typically with
dramatic response to corticosteroid therapy [6].
Orbital pseudotumor is commonly restricted to the
orbit; however, an extension beyond the orbit can occur,
usually in the middle cranial fossa and cavernous sinus,
in cases of extensive and chronic inflammation [7],
through one of the three major posterior orbital open-
ings: the superior orbital fissure (SOF), the optic canal,
and the inferior orbital fissure. Extraorbital extension of
orbital pseudotumor in the adjacent paranasal sinuses
[8–10], and into the infratemporal and pterygopalatine
fossae [11] has also been rarely reported.
Magnetic Resonance Imaging (MRI) is the best technique
for imaging orbital pseudotumor, although MRI findings
may be nonspecific, and for evaluating its extraorbital ex-
tension. The pseudotumor infiltrate in the orbit typically
demonstrates low signal intensity on T1-weighted images
and frequently on T2-weighted images, depending on the
degree of fibrosis, with the sclerosing variety being the most
T2-hypointense. Marked gadolinium enhancement is
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usually present [12]. Orbital pseudotumor may thus mimick
several disease entities, including infection, lymphoma, sar-
coidosis, and other granulomatous diseases [12, 13]; there-
fore, it is often a diagnosis of exclusion, based on history,
clinical course, response to steroid therapy, laboratory tests,
or even biopsy in selected cases.
The intracranial extension of orbital pseudotumor, al-
though rare (8.8 % in a Computed Tomography series),
has been previously reported [14–26], and usually in-
volves the middle cranial fossa (MCF) and the cavernous
sinus (CS) through the SOF, appearing as an enhancing
nodular or plaque-like thickening of the dura mater, as
summarized in our literature review (Table 1). In par-
ticular, the 3 patterns identified by Clifton et al. [17] still
represent the paradigm of the intracranial involvement,
eliciting variable edema in the brain tissue contiguous to
the extra-axial infiltrate. Here we report the first case, to
the best of our knowledge, of orbital pseudotumor pre-
senting with brain MRI findings indicative of intra-axial
changes.
Case presentation
A 57-year-old obese smoker woman presented with a
three-month history of debilitating, daily right-sided
Table 1 Previously reported cases of orbital pseudotumor with intracranial extension
Year Author Patient age
(years)
Gender Intracranial location/features
1984 Kaye et al. 71 M ACF (planum sphenoidale), dural-based
1986 Frohman et al. 48 M SOF, optic canal, bone erosion
48 F MCF/CS, bone erosion
72 M SOF, bone erosion
1986 Noble et al. 46 F ACF, dural thickening
1992 Clifton et al. 49 M MCF/CS, pattern II
69 M SOF, pattern I
54 F MCF/CS, pattern II
36 M MCF, pattern I
86 M MCF/CS, dural thickening, bilateral involvement, pattern III
71 F MCF/CS, pattern II
30 M MCF/CS, dural thickening, pattern III
61 M MCF/CS, pattern II
1993 Bencherif et al. 23 M CS, SOF, left fronto-temporal dural thickening, sphenoid bone sclerosis
1993 Olmos et al. 64 F CS/Meckel cave, parasellar plaque, dural surface down to clivus and C2 body
1996 de Jesus et al. 16 F Optic canal, SOF, MCF; dural thickening of the left hemisphere and tentorium
1998 Soares et al. - - Pituitary fossa/CS, ICA compression
2000 Ayala et al. 83 F ACF extra-axial mass without bone involvement, (possibly through the anterior etmoid
foramen)
2004 Mahr et al. 40 M MCF, dural thickening over the temporal pole
41 M Optic canal, MCF paraclinoid mass
73 F Meckel cave/CS
2005 Lee et al. 58 M MCF/CS, dural thickening; ICA encasement
63 M SOF
55 M MCF/CS, petrous apex, dural thickening; brain edema; ICA encasement
32 M MCF/CS dural thickening; brain edema
46 M MCF/CS, petrous apex, Meckel cave, dural thickening; brain edema; ICA encasement
2006 Zborowska et al. 45 F MCF/CS, Meckel cave, dural thickening over the temporal pole
32 M MCF/CS, pituitary fossa, tentorium; bone erosion (sphenoid wing and orbital roof)
48 F MCF/CS; parasellar mass, bone erosion, ICA encasement
2011 Saifudheen
et al.
50 M MCF/CS large dural mass (temporal pole); brain edema
ACF Anterior cranial fossa, MCF Middle cranial fossa, CS Cavernous sinus, SOF Superior orbital fissure, ICA Internal carotid artery, Pattern I, II, III: patterns of
intracranial extension of orbital pseudotumor as described by Clifton et al. [17]
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headache, worsening with eye movement, right palpebral
edema and blurred vision. Her medical history included
anxiety, depression and hypertension. Laboratory data
showed increased C-reactive protein (5,75 mg/L),
erythrocyte sedimentation rate (56 mm/h) and hematic
fibrinogen (529 mg/dL). Clinical examination and fun-
doscopy revealed right conjunctival chemosis, temporal
muscle edema, palpebral edema and ptosis, and ill-
defined optic disk with papilledema. The visual field and
neurological examination were normal.
The patient underwent contrast-enhanced (CE) MRI
scan of the brain and orbits, at 1.5 Tesla, with FLAIR
(TR: 8005 ms, TE: 100 ms, TI: 2200 ms, matrix: 256x192,
slice thickness: 5 mm), STIR (TR: 2650 ms, TE: 90 ms,
TI: 180 ms, matrix: 256x204, slice thickness: 3 mm) and
Fast Spin-Echo T1- and T2-weighted (TR: 583–4454 ms,
TE: 15–100 ms, matrix: 244x194-384x288, slice thick-
ness: 5 mm, respectively) sequences, acquired before and
after intravenous administration of Gadobutrol (Bayer
HealthCare, 0.1 mmol/Kg). Also, MR angiography of the
intracranial arterial and venous systems was performed
using 3D and 2D time-of-flight (TOF) sequences,
respectively. The MRI scan showed enlargement of the
lateral rectus muscle in the right orbit, involving the an-
terior tendon insertion, infiltration and obliteration of
the contiguous fat due to a homogenous T2-hypointense
tissue, with marked contrast-enhancement; similar
changes were demonstrated in the temporal and the
pterygoid muscles within the right masticator space
(Fig. 1).
A number of intracranial findings were also detected:
massive vasogenic edema of the anterior portion of the
right temporal lobe, associated with thickening and
enhancement of the contiguous dura (adjacent to the
sphenoid wing) and with striking sub-cortical enhance-
ment, that increased at 1 h (Fig. 2). The cavernous si-
nuses were normal; at MR venography, absence of flow
signal in the right spheno-parietal sinus was observed,
due to venous compression, with no signs of thrombosis.
Also, unenhanced brain Computed Tomography con-
firmed the intracranial/extracranial edematous changes
and disclosed sclerotic reaction of the right sphenoid
wing with focal cortical erosion (not shown).
Signs of systemic diseases such as autoimmune disorders
were searched using chest x-ray and laboratory tests, in-
cluding anti-nuclear antibodies, anti-neutrophil cytoplas-
mic antibodies, C3, C4, and angiotensin-converting
enzyme blood levels, all showing no abnormalities. A lum-
bar puncture was refused by the patient.
Orbital pseudotumor with intracranial involvement
was therefore suspected, and the patient was started on
steroid therapy (i.v. dexamethasone, 8 mg daily for 4
days, followed by 4 mg for other 4 days, and then ta-
pered with the oral solution).
Biopsy was proposed to the patient as a necessary integra-
tion to rule out other possible conditions (e.g. lymphoma)
Fig. 1 Orbital and extraorbital involvement before and after steroid therapy. Upper row: coronal STIR (a, b) and axial FLAIR (c) MR images before
treatment. Lower row: coronal STIR (d, e) and axial FLAIR (F) MR follow-up images after steroid therapy. Evidence of marked enlargement and
edema involving the lateral rectus muscle in the right orbit, with infiltration of the contiguous fat (a), and the temporal and pterygoid muscles in
the ipsilateral masticator space (b), all showing complete regression at follow-up (d, e). The massive vasogenic edema of the anterior portion of
the temporal lobe evident in the initial MR scan (c), also shows dramatic reduction at follow-up (f)
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in the acute phase. However, it was firmly refused by the
patient.
Ten days later, follow-up CE-MRI showed dramatic im-
provement of the intraorbital and extracranial findings, of the
dural thickening and of the temporal vasogenic edema, with
complete regression of brain enhancement (Figs. 1 and 3),
making, at this stage, the biopsy unnecessary. At 6 and 12
month follow-up, the patient continued to do well and her
only complaint was mild headache. Further CE-MRI
follow-up at 2 years without therapy showed return-to-
normal of intraorbital structures, disappearance of intraor-
bital and intracranial enhancement, and persistence of a
Fig. 2 Early and delayed intracranial enhancement in the acute phase. Axial CE T1w MR images before treatment at the level of the middle
cranial fossa obtained 5 min (a) and 1 h (b) after iv administration of Gadolinium. Substantial thickening and intense enhancement of the dura
mater adjacent to the right sphenoid wing can be appreciated (a), as well as involvement of the sub-cortical white matter of the temporal pole,
that increases in the delayed phase (b). The temporal muscle also appears markedly enlarged and intensely enhancing compared to the
contralateral one
Fig. 3 Intracranial enhancement before and after steroid therapy. Coronal (a, c) and sagittal (b, d) CE T1w MR images before (upper row) and after
(lower row) steroid therapy. In the follow-up phase, CE-MRI (C-D) shows striking improvement of the dural thickening and complete regression of the
intra-axial enhancement
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small gliotic subcortical scar in the right temporal pole
(not shown), reasonably ruling out a diagnosis of lymph-
oma. The patient is still periodically seen in our Institute
(now at 2.5 years), and reports no further episodes of or-
bital swelling nor headache.
In our patient, the subcortical temporal pole enhance-
ment, which increased in the delayed phase (Fig. 2), rep-
resented the intra-axial consequences of the intracranial
orbital pseudotumor extension, which, to our knowledge,
have never been previously described.
In our opinion, a possible pathophysiological explan-
ation of the observed findings may take origin from the
compression of the loco-regional venous system, due to
the meningeal extension of the pseudotumor, even if
small, as demonstrated by the impaired visualization of
the right spheno-parietal sinus at MR venography. It is
known that cerebral venous thrombosis could lead to
both vasogenic edema and brain parenchymal enhance-
ment [27], which can be either reversible or irreversible
[28], allowing us to hypothesize the presence of sinus
venous compression in the present case, with patho-
physiological consequences similar to vein thrombosis. A
state of venous hypertension of the cortical veins of the
temporal pole, without actual thrombosis (that was not
present in any of the CE-MRI scans), may thus have led
to hampered venous drainage, with damage of the
blood–brain barrier with increased permeability and CE
in the temporal lobe ensuing as a functional conse-
quence, which resolved after successful therapy (Fig. 3).
The associated vasogenic edema was therefore due to
the venous hypertension and not to the orbital pseudotu-
mor mass itself, as also supported by the discrepancy
between the small actual bulk of the intracranial
pseudotumoral tissue and the large extent of intra-axial
vasogenic edema (Figs. 1, 2 and 3).
We have reviewed all orbital pseudotumor cases with
intracranial extension that we could retrieve in the litera-
ture (Table 1). Compared to our patient, most cases ex-
hibited somewhat similar features, such as the extra-axial
involvement of MCF – CS, and mild vasogenic edema as
the only intra-axial finding. However, none of them
showed intra-axial enhancement and large subcortical
edema, thus mimicking intra-axial pathology, which, in-
stead, were demonstrated in our case using delayed CE-
MRI acquisitions. We could also document a complete
regression of the intra/extra-cranial findings, due to ser-
ial MRI scans over a 2-year follow-up, not available in
most other reported cases.
Conclusions
In conclusion, this case serves as a reminder that chronic
inflammatory orbital pseudotumor can extend intracrani-
ally, possibly inducing serious neurological symptoms,
and even showing MRI changes mimicking intra-axial
pathology. Although invasive orbital pseudotumors are
uncommon, they should be considered in the differential
diagnosis of orbital masses extending beyond the con-
fines of the bony orbit. CE-MRI is the method of choice
to evaluate both extracranial and intracranial pathology,
possibly with delayed acquisitions, and may help, along
with biopsy, in recognizing these rare findings and in
monitoring the appropriate therapy.
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